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Study Objectives: Prospective data evaluating abnormal sleep quality and quantity with cognitive decline are limited because most studies used subjective 
data and/or had short follow-up. We hypothesized that, over 15 y of follow-up, participants with objectively measured obstructive sleep apnea (OSA) and other 
indices of poor sleep quantity and quality would experience greater decline in cognitive functioning than participants with normal sleep patterns.
Methods: ARIC participants (n = 966; mean age 61 y, 55% women) with in-home polysomnography (1996–1998) and repeated cognitive testing were 
followed for 15 y. Three cognitive tests (Delayed Word Recall, Word Fluency, and Digit Symbol Substitution) were administered at two time points (1996–1998 
and 2011–2013). Ten additional cognitive tests were administered at the 2011–2013 neurocognitive examination. OSA was modeled using established clinical 
OSA severity categories. Multivariable linear regression was used to explore associations of OSA and other sleep indices with change in cognitive tests 
between the two assessments.
Results: A median of 14.9 y (max: 17.3) passed between the two cognitive assessments. OSA category and additional indices of sleep (other measures of 
hypoxemia and disordered breathing, sleep fragmentation, sleep duration) were not associated with change in any cognitive test. Analyses of OSA severity 
categories and 10 cognitive tests administered only in 2011–2013 also showed little evidence of an association.
Conclusions: Overall, abnormal sleep quality and quantity at midlife was not related to cognitive decline and later-life cognition. The effect of adverse sleep 
quality and quantity on cognitive decline among the elderly remains to be determined.
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INTRODUCTION
Dementia and mild cognitive impairment (MCI) are common 
among US elderly.1 Yet, despite the immense and growing 
burden of these conditions, gaps exist in the understanding of 
characteristics leading to cognitive decline. Recent evidence, 
both epidemiological and pathophysiological, has suggested a 
possible association between abnormal sleep quality and quan-
tity and cognitive impairment due to both cerebral vascular 
etiologies and Alzheimer disease.2–6 However, understanding 
of the underlying associations is incomplete.
In an acute setting, it is well established that poor sleep 
quality and curtailment of sleep duration is associated with 
worse cognitive function.3 However, evidence is limited re-
garding whether long-standing impairments in sleep quality 
and quantity have long-lasting effects on cognitive function. 
Dementia and MCI are believed to have a long preclinical 
phase and the etiologically relevant stage of life may be middle 
age, as has been suggested with other risk factors for cogni-
tive decline (e.g., hypertension,7,8 diabetes,9–12 smoking13). Most 
prospective work exploring associations of sleep quantity and 
quality with cognitive decline has used subjective measures 
of sleep which have limited accuracy,14 had limited follow-
up, and/or has focused on older individuals,15–18 in whom 
pathophysiological processes through which sleep results in 
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Significance
Cognitive decline among older adults is a major public health concern, yet effective interventions to prevent cognitive decline are elusive. Intriguing 
research conducted largely in cross-sectional samples and animal models has suggested that obstructive sleep apnea (OSA) and other indices of poor 
sleep quantity and quality may result in cognitive decline. Counter to prior evidence, using observational data from nearly 1,000 individuals who were 
followed for about 15 years, there was no relation between sleep characteristics and cognitive decline. Although these results dampen enthusiasm about 
the role of sleep in cognitive decline, there are important methodological considerations—namely selection bias, statistical power, and the length of 
follow-up—that need to be taken into account when interpreting these findings.
cognitive decline may be well underway. There are several 
mechanisms through which poor sleep quality and habitual 
short sleep duration may affect cognitive decline,3,4 which in-
clude: cyclical nocturnal hypoxemia,19–21 sleep fragmentation,22 
mediation through cardiovascular disease risk factors (e.g. hy-
pertension, diabetes, inflammation), stroke (both clinical and 
subclinical),21,23,24 Aβ plaque buildup5, and interaction with the 
apolipoprotein E (APOE) ε4 risk allele.6,25
In a subset of the Atherosclerosis Risk in Communities 
(ARIC) study population who participated in the Sleep Heart 
Health Study (SHHS), we evaluated the associations between 
the severity of obstructive sleep apnea (OSA), degree of sleep 
fragmentation, and habitual sleep duration – assessed in middle 
age – with 15-y change in cognitive functioning test scores. 
We hypothesized that participants with disordered breathing 
during sleep, sleep disruption, and habitually short sleep dura-
tion would experience greater decline in cognitive function, as 
assessed by change on three cognitive tests [the Delayed Word 
Recall Test (DWRT), the Word Fluency Test (WFT), and the 
Digit Symbol Substitution Test (DSST)], which were adminis-
tered at the time of the sleep exam (ARIC visit 4; 1996–1998) 
and repeated at the ARIC neurocognitive examination (ARIC 
visit 5; 2011–2013). Second, we examined the association be-
tween the severity of OSA and an additional 10 tests spanning 
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several domains of cognitive functioning assessed as part of 
the follow-up neurocognitive examination.
METHODS
Study Design Overview
The ARIC study is a prospective cohort which in 1987–1989 
enrolled 15,792 men and women aged 45–64 years using prob-
ability sampling from four US communities (visit 1).26 A total 
of four cohort reexaminations have taken place (visit 2: 1990–
1992, visit 3: 1993–1995, visit 4: 1996–1998, visit 5: 2011–
2013). Hospitalizations and mortality for ARIC participants 
have been tracked continuously since study enrollment though 
annual phone calls (semiannual since 2012), surveillance of 
local hospitals, and monitoring of state and national death in-
dexes. Institutional review boards at each of the participating 
institutions approved the study protocols, and all participants 
provided informed consent at each study visit.
In 1996–1998 (visit 4, baseline for the current study) a subset 
of 1,920 ARIC participants from the Washington County, MD 
and suburban Minneapolis, MN field centers were recruited 
into the SHHS20 and underwent an in-home overnight poly-
somnogram (PSG). Virtually all participants recruited from 
the MD and MN centers were white. Cognitive function as 
measured by the DWRT, WFT, and DSST tests took place at 
ARIC visits 2, 4, and 5. As part of visit 5, also referred to here 
as the follow-up neurocognitive examination, extensive cogni-
tive testing was done with the overall objective to determine 
the prevalence of cognitive impairment and dementia and 
the associations of midlife vascular risk factors and markers 
with later-life cognitive impairment, cognitive decline, and 
dementia.27 Participants were invited for examinations in the 
study clinic or in their homes or in long-term care facilities.
Of the 1,920 SHHS participants, we excluded 193 partici-
pants with incomplete data on OSA severity, 32 with central 
sleep apnea, 203 with incomplete data on cognitive tests and/
or covariates of interest, and 506 who did not participate in 
the follow-up neurocognitive examination due to either death 
(n = 277) or refusal to participate (n = 229). Our final analytic 
sample included 966 participants.
Sleep Measurements
The overnight unattended PSG was conducted using a portable 
monitor (PS-2 System; Compumedics Limited, Abbotsford, 
Victoria, Australia), using methods previously described.21 
As in prior analyses of SHHS data, an apnea was considered 
present if there was an absence or near-absence of airflow (at 
least < 25% of baseline) for ≥ 10 sec.28,29 Hypopnea was de-
fined as a decrease in the amplitude of the airflow below 70% 
of baseline for ≥ 10 sec. The apnea-hypopnea index (AHI) 
was defined as the average number of obstructive apneas 
(any apnea, regardless of the oxygen desaturation level) plus 
hypopneas (with at least a 4% decrease in oxygen saturation), 
per hour of sleep. As has been done previously in SHHS, par-
ticipants were categorized into four OSA severity groups ac-
cording to the AHI: < 5.0 events/h (normal), 5.0–14.9 events/h 
(mild sleep apnea), 15.0–29.9 events/h (moderate sleep apnea), 
and ≥ 30.0 events/h (severe sleep apnea). Central sleep apnea 
events, which were defined by the absence of airflow with no 
associated respiratory effort detected, were excluded from this 
definition. Information on measurement of other sleep related 
variables is provided in the supplemental material.
Cognitive Testing
Three cognitive tests were administered at the time of the sleep 
examination (1996–1998) and repeated at the follow-up neuro-
cognitive examination (2011–2013): the DWRT, DSST, and WFT.
Digit Symbol Substitution Test (DSST)30
Tests executive function and processing speed; participants are 
asked to translate numbers to symbols using a key. The score 
is the total number of digits correctly translated to symbols 
within 90 sec and the range of possible scores is 0 to 93.
Delayed Word Recall Test (DWRT)31
Tests verbal learning and recent memory. Participants are pre-
sented with 10 common nouns that they are asked to use in a 
sentence. Two exposures to the words are given. After a 5-min 
delay, participants are given 60 sec to recall the words. The 
score for the DWRT is the number of words correctly recalled.
Word Fluency Test (WFT)32
Tests executive function and language. Participants are given 
60 sec to generate as many words as possible beginning with 
the letters F, A, and S (60 sec for each letter), avoiding proper 
nouns. The WFT score is the total number of acceptable words 
generated for the three letters.
In general, low scores on the DWRT are more reflective of 
memory impairment and Alzheimer disease; whereas low 
scores on the WFT and DSST are more strongly associated 
with executive function and cerebral vascular dementia.33
The cognitive battery administered at the follow-up neuro-
cognitive examination was much more extensive, and included 
most of the neuropsychological tests recommended for inclu-
sion in the National Institute of Aging’s National Alzheimer’s 
Disease Coordinating Center’s (NACC) Uniform Data Set Bat-
tery34: Trail Making Test, part A; Trail Making Test, part B; 
Digit Span Backwards, Logical Memory Test, part A; Logical 
Memory Test, part B; Incidental Learning, digit-symbol pairs; 
Clock Time Perception. Protocols for the tests, which have 
been described elsewhere, were standardized and examiners 
were trained centrally. The tests were administered in a fixed 
order during one session in a quiet room.
Statistical Analysis
Standardized z-scores for each cognitive test were calculated 
by subtracting the mean and dividing by the standard deviation 
(SD). For the DSST, DWRT, and WFT, z-scores were created 
based on the means and SD at visit 2 (when the first cognitive 
assessment was done), which was then applied to the distribu-
tions at the sleep (1996–1998) and follow-up neurocognitive 
(2011–2013) examinations. z-scores for the tests only admin-
istered at the follow-up neurocognitive examination were cal-
culated using the means and SD among individuals eligible 
for this analysis. For the Trail Making tests z-scores were 
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calculated using the log of the test scores. In 
addition, because a higher score on this test in-
dicates worse performance, the z-scores were 
multiplied by −1 so that low z-scores indicated 
worse performance across all tests.
Participant characteristics (% or mean ± 
SD) are provided stratified by OSA severity 
and, separately, by follow-up neurocogni-
tive examination participation status. For 
continuous variables, the linear trend across 
OSA categories was tested by modeling OSA 
categories ordinally. For categorical variables, 
the Cochran-Armitage trend test was used. 
To evaluate change in the DSST, DWRT, and 
WFT tests between the sleep and follow-up 
neurocognitive examinations, multivariable 
linear regression was used with the outcome 
being the follow-up neurocognitive examina-
tion z-score minus the sleep exam z-score. For 
cognitive function tests only measured at the 
follow-up neurocognitive examination, multi-
variable linear regression was also used, with 
the outcome being the follow-up neurocogni-
tive examination z-score. OSA was modeled 
using established clinical OSA severity catego-
ries; dummy variables for each category were 
included in the regression model. Other indices 
of sleep quality and quantity were modeled 
as continuous variables, per 1 SD. Quadratic 
terms were included in the models to assess 
nonlinearity, and if evidence of nonlinearity 
was present, the sleep variables of interest 
were modeled as quartiles. 
A series of nested models were explored; 
covariates came from the sleep examination, 
unless otherwise noted. Model 1 adjusted for 
age, sex, field center, and educational attain-
ment (visit 1). Model 2 further adjusted for 
ethanol intake, smoking status, leisure time 
physical activity (visit 3), and APOE ε4 risk 
allele. Model 3 additionally adjusted for body 
mass index (BMI). Model 4 also adjusted for 
characteristics believed to be on the causal 
pathway between OSA and cognitive decline 
(i.e., high-sensitivity C-reactive protein (CRP), diabetes mel-
litus, hypertension, and prevalent coronary heart disease, heart 
failure, and stroke).
In sensitivity analyses, to account for attrition due to ei-
ther death or failure to attend the follow-up neurocognitive 
examination (censoring), we incorporated inverse probability 
of attrition weighting (IPAW) methods,35 as has been done 
previously with the ARIC follow-up neurocognitive data.27 
Weights for each individual were the inverse of the product of 
the estimated probability of being alive and the probability of 
participating in the study (conditional on being alive). Charac-
teristics included in the IPAW weighting models are provided 
in the supplemental material. We also calculated stabilized 
weights35 by multiplying our original weights by probabilities 
of follow-up neurocognitive examination participation calcu-
lated using only baseline age, sex, and educational level.
RESULTS
Of the original 1,472 SHHS participants, 966 participated in 
the ARIC follow-up neurocognitive examination and were in-
cluded in our final analytic sample, whereas 506 (34%) were 
not included due to death, attrition, or incomplete cognitive 
testing information. Relative to those who did not participate 
in the follow-up neurocognitive examination, those who par-
ticipated tended, at the time of the sleep examination, to be 
younger, have higher educational attainment, and have a lower 
prevalence of cardiovascular diseases and risk factors (Table 1). 
Overall, when stratified by OSA category, characteristics of 
Table 1—Participant characteristics at the sleep examination (visit 4; 1996–1998), 
stratified by neurocognitive follow-up examination (visit 5; 2011–2013) participation status.
 Neurocognitive Follow-Up Examination
Participant (n = 966) Nonparticipant (n = 506)
Age, y 61.3 ± 5.0 65.1 ± 5.5
Female 51.4 48.6
Education ≥ high school graduate 91.8 84.8
Leisure time physical activity 2.6 ± 0.5 2.5 ± 0.5
Smoking status
Current 8.7 13.6
Former 48.6 49.0
Never 42.8 37.4
Usual ethanol intake, g/w 39.6 ± 70.9 37.2 ± 78.5
BMI, kg/m2 28.5 ± 4.8 29.1 ± 5.4
Hypertension 33.1 49.2
Diabetes mellitus 8.5 16.2
Prior stroke 0.4 3.8
Prior heart failure 2.1 7.5
Prior coronary heart disease 5.7 14.2
C-reactive protein 3.6 ± 5.2 4.5 ± 6.3
APOE ε4 risk allele 
0 72.6 67.8
1 25.3 27.5
2 2.2 4.7
Obstructive sleep apnea
Normal 53.9 46.8
Mild 28.5 32.2
Moderate 12.2 13.2
Severe 5.4 7.7
Delayed Word Recall 6.8 ± 1.4 6.4 ± 1.6
z-score 0.2 ± 0.9 0.1 ± 1.0
Word Fluency 37.7 ± 10.8 34.7 ± 11.3
z-score 0.4 ± 0.9 0.12 ± 0.90
Digit Symbol Substitution 50.8 ± 10.2 45.1 ± 10.8
z-score 0.4 ± 0.7 0.03 ± 0.8
Values correspond to mean ± standard deviation or %. Visit 5 status defined as attending 
the fifth study visit regardless of cognitive test completion status. All characteristics differed 
(P < 0.05) across visit 5 participation status, except ethanol intake. APOE, apolipoprotein 
E; BMI, body mass index.
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the entire SHHS sample were similar to those of our final ana-
lytic sample (Table S1, supplemental material versus Table 2).
The 966 ARIC participants included in our final analytic 
sample were on average 61.3 ± 5.0 y old and 51.4% female 
when the baseline sleep study (1996–1998) was conducted. Of 
these participants, 5.4% (n = 52) were classified as having se-
vere OSA, 12.2% (n = 118) as having moderate OSA, 28.5% 
(n = 275) as having mild OSA, and 53.9% (n = 521) as having 
a normal sleep breathing pattern. Relative to participants clas-
sified as normal, those with severe OSA were more likely to 
be male, have a higher BMI, have a higher CRP level, and to 
be hypertensive, diabetic, and have prevalent heart failure or 
coronary heart disease (Table 2).
A median of 14.9 y (max: 17.3 y) passed between the cogni-
tive assessments at the sleep and follow-up neurocognitive ex-
aminations. Over this time cognitive performance decreased, 
according to mean (± SD) scores (raw score / z-score) on 
the DWRT (−1.64 ± 1.97 / −1.08 ± 1.30), WFT (−2.42 ± 8.68 
/ −0.19 ± 0.69), and DSST (−8.57 ± 7.27 / −0.60 ± 0.51). As-
sociations between OSA severity categories and linear change 
in cognitive test scores between the sleep and follow-up neu-
rocognitive examinations are presented in Table 3. There was 
no association between OSA category and change in DWRT, 
WFT, or DSST, regardless of degree of adjustment. Results 
were similar when we accounted for attrition by employing in-
verse probability weighting and stabilized inverse probability 
weighting models (Tables S2 and S3, supplemental material).
We also examined associations between measures of disor-
dered breathing, including severity of nocturnal hypoxemia 
and sleep fragmentation, habitual sleep duration, and change 
in scores on the DWRT, WFT, and DSST tests. Overall, there 
was no evidence of an association (Table 4). For measures of 
disordered breathing including nocturnal hypoxemia and sleep 
fragmentation, which were modeled continuously, there also 
was no evidence of nonlinearity. The only evidence of an as-
sociation was that, across all models, participants with habitu-
ally short sleep duration (< 7 h) experienced a slightly greater 
decline in DSST scores relative to participants who slept 7 to 
8 h: mean change (95% confidence interval [CI]): Model 1: 
−0.10 (−0.18, −0.02); Model 2: −0.11 (−0.19, −0.03); Model 3: 
−0.10 (−0.19, −0.02); Model 4: −0.10 (−0.19, −0.02). Overall, re-
sults were similar when IPAW or stabilized IPAW were used 
(Table S4, supplemental material). For the association be-
tween sleep duration and DSST, estimates which accounted for 
Table 2—Demographic and clinical characteristics of the final analytic sample (n = 966) at the sleep examination (visit 4; 1996–1998), stratified by sleep 
examination obstructive sleep apnea categories.
 Normal (n = 521) Mild (n = 275) Moderate (n = 118) Severe (n = 52)
Age, years 60.7 ± 5.1 61.8 ± 4.8 62.3 ± 5.2 62.4 ± 4.5
Female 66.6 45.1 32.2 38.5
Education ≥ high school graduate 93.5 89.8 90.7 88.5
Leisure time physical activity 2.6 ± 0.5 2.5 ± 0.5 2.6 ± 0.4 2.5 ± 0.6
Smoking status
Current 11.1 5.5 5.1 9.6
Former 44.2 52.7 56.8 51.9
Never 44.7 41.8 38.1 38.5
Usual ethanol intake, g/w 37.9 ± 66.8 45.0 ± 82.4 37.0 ± 63.9 33.1 ± 59.3
BMI, kg/m2 27.0 ± 4.3 29.4 ± 4.3 30.6 ± 4.9 33.5 ± 5.4
Hypertension 29.8 35.3 35.6 50.0
Diabetes mellitus 5.8 11.3 7.6 23.1
Prior stroke 0.4 0.7 0.0 0.0
Prior heart failure 1.5 2.6 2.5 3.9
Prior coronary heart disease 5.4 5.1 8.5 5.8
C-reactive protein 3.6 ± 5.1 3.5 ± 5.5 3.6 ± 4.9 5.0 ± 4.9
APOE ε4 risk allele 
0 70.3 74.2 78.8 73.1
1 27.5 23.3 19.5 26.9
2 2.3 2.6 1.7 0.0
Delayed Word Recall 7.0 ± 1.4 6.6 ± 1.5 6.6 ± 1.4 6.8 ± 1.1
z-score 0.3 ± 0.9 −0.01 ± 1.0 −0.04 ± 1.0 0.1 ± 0.7
Word Fluency 38.3 ± 10.7 37.5 ± 11.1 36.1 ± 10.7 36.2 ± 10.1
z-score 0.4 ± 0.9 0.3 ± 0.9 0.2 ± 0.9 0.2 ± 0.8
Digit Symbol Substitution 52.3 ± 10.4 49.3 ± 9.9 49.1 ± 9.2 48.9 ± 9.2
z-score 0.5 ± 0.7 0.3 ± 0.7 0.3 ± 0.6 0.3 ± 0.6
Values correspond to mean ± standard deviation or proportion. All characteristics differed (P < 0.05) across obstructive sleep apnea categories, except for 
education, prevalent coronary heart disease, and prevalent stroke.
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attrition were slightly stronger; the Model 1 IPAW estimated 
change was −0.15 (−0.26, −0.05), while the Model 1 stabilized 
IPAW estimate was −0.14 (−0.23, −0.05).
Table 5 presents associations between sleep examination 
OSA severity categories and 10 cognitive tests administered 
only at the follow-up neurocognitive examination, as well as 
the follow-up neurocognitive examination values (not change) 
for the DWRT, WFT, and DSST. For the Trail Making Test, 
part A, there was evidence of a linear trend (P trend = 0.03) 
whereby participants with greater OSA severity at the sleep ex-
amination had worse scores on this test. This association per-
sisted across all statistical models (data not shown). Those with 
severe OSA also had lower scores on the Clock Time Percep-
tion tests (−0.29 [−0.52, −0.05]) relative to those who had no 
evidence of OSA (Table 5). This association was also present 
across all models (data not shown).
DISCUSSION
In a community-based sample of nearly 1,000 individuals we 
evaluated the association between abnormal indices of sleep 
quality and quantity, measured objectively in middle age, with 
15-y change in cognitive test scores. Overall, we found no evi-
dence that severity of OSA, degree of nocturnal hypoxemia, 
sleep fragmentation, or habitual sleep duration were associ-
ated with cognitive decline. In secondary analyses exploring 
the association between OSA severity and tests spanning mul-
tiple cognitive domains, which were only administered 15 y 
after the sleep study, there was also no evidence of an associa-
tion between midlife OSA and later life cognition. The lack of 
a prospective association of sleep quality and quantity with 
later-life cognition was counter to our hypothesis, which con-
sidered midlife as the etiologically relevant frame for evalu-
ating the association between OSA and cognitive decline.
The strongest existing epidemiologic evidence that sleep 
may be associated prospectively with cognitive decline comes 
from the Study of Osteoporotic Fractures, which has evaluated 
prospectively the relation between objectively measured sleep 
and risk of incident MCI and dementia (combined outcome).4 
Over a median 4.7 y, after multivariable adjustment women 
(median age, 82.3 y) with moderate or severe OSA, were 85% 
more likely to develop MCI or dementia.4 The relation be-
tween subjectively measured sleep quality and quantity with 
Table 3—Adjusted mean change and 95% confidence intervals from linear regression models for change in cognitive score from sleep exam (visit 4; 
1996–1998) to the neurocognitive follow-up examination (visit 5; 2011–2013) (z-scores standardized to visit 2; 1990–1992) stratified by obstructive sleep 
apnea categories.
 Normal (n = 758) Mild (n = 438) Moderate (n = 185) Severe (n = 91) P for trend
Delayed Word Recall change
Number with visit 4 and visit 5 data 511 271 118 51
Unadjusted change in raw score −1.59 ± 2.01 −1.66 ± 1.94 −1.68 ± 1.90 −1.98 ± 1.87
Unadjusted change in z-score −1.04 ± 1.32 −1.10 ± 1.28 −1.10 ± 1.25 −1.30 ± 1.23
Model 1 Reference 0.01 (−0.18, 0.20) 0.02 (−0.23, 0.27) −0.16 (−0.51, 0.18) 0.65
Model 2 Reference 0.00 (−0.19, 0.19) 0.00 (−0.25, 0.25) −0.19 (−0.52, 0.14) 0.49
Model 3 Reference 0.02 (−0.17, 0.22) 0.03 (−0.23, 0.29) −0.14 (−0.49, 0.22) 0.78
Model 4 Reference 0.02 (−0.18, 0.21) 0.03 (−0.23, 0.28) −0.14 (−0.48, 0.21) 0.76
Word Fluency change
Number with visit 4 and visit 5 data 512 273 116 52
Unadjusted change in raw score −2.42 ± 8.47 −2.53 ± 8.92 −2.17 ± 8.81 −2.46 ± 9.41
Unadjusted change in z-score −0.19 ± 0.68 −0.20 ± 0.71 −0.17 ± 0.70 −0.20 ± 0.75
Model 1 Reference 0.03 (−0.07, 0.13) 0.06 (−0.08, 0.21) 0.05 (−0.15, 0.26) 0.35
Model 2 Reference 0.01 (−0.09, 0.11) 0.05 (−0.09, 0.19) 0.05 (−0.16, 0.25) 0.48
Model 3 Reference 0.03 (−0.08, 0.13) 0.07 (−0.07, 0.21) 0.09 (−0.13, 0.30) 0.27
Model 4 Reference 0.03 (−0.08, 0.14) 0.07 (−0.07, 0.21) 0.09 (−0.13, 0.31) 0.25
Digit Symbol Substitution change
Number with visit 4 and visit 5 data 513 267 114 51
Unadjusted change in raw score −8.26 ± 7.37 −8.63 ± 6.95 −9.25 ± 6.70 −9.76 ± 9.00
Unadjusted change in z-score −0.58 ± 0.52 −0.61 ± 0.49 −0.65 ± 0.47 −0.69 ± 0.63
Model 1 Reference −0.02 (−0.09, 0.05) −0.06 (−0.15, 0.03) −0.09 (−0.26, 0.09) 0.17
Model 2 Reference −0.02 (−0.09, 0.05) −0.07 (−0.16, 0.03) −0.09 (−0.26, 0.09) 0.14
Model 3 Reference 0.00 (−0.08, 0.07) −0.04 (−0.14, 0.06) −0.04 (−0.23, 0.14) 0.45
Model 4 Reference 0.00 (−0.08, 0.07) −0.04 (−0.14, 0.05) −0.04 (−0.22, 0.14) 0.48
Change modeled as the follow-up neurocognitive exam (visit 5; 2011–2013) z-score minus the sleep exam (visit 4; 1996–1998) z-score; negative values 
correspond to greater decline compared to the reference (normal sleep category). P for trend from linear regression model with obstructive sleep apnea 
modeled as an ordinal variable: Model 1 adjusted for age, sex, field center, and educational ascertainment. Model 2 adjusted for Model 1 and ethanol intake, 
smoking status, leisure time physical activity, and apolipoprotein E ε4 risk allele. Model 3 adjusted for Model 2 and body mass index. Model 4 adjusted for 
Model 3 and high-sensitivity C-reactive protein, diabetes mellitus, hypertension, and prevalent coronary heart disease, heart failure, or stroke.
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incident cognitive decline has been evaluated in several prior 
studies.15–18 Recently, self-reported short and long sleep dura-
tion was associated with higher risk of MCI and dementia in 
a large prospective study of older women who were followed 
from 1995–2008.36 Results of the other studies were mixed, but 
they were limited by short follow-up (at most 3 y), and making 
direct comparisons is difficult as they used varying measures 
of sleep disturbances and cognition.
Although several other risk factors for cognitive decline 
show stronger associations when measured in midlife,7,9–11,13 it 
is possible that if poor sleep quality and/or quantity and disor-
ders such as OSA are causally associated with cognition, their 
effect may be more acute. As has been reviewed by others,37 
several small, short, randomized trials of patients with OSA 
have reported modest improvements in cognitive functioning 
after continuous positive airway pressure therapy for OSA, 
with the greatest gains observed in the executive function do-
main.38 Cross-sectional studies have suggested that poor sleep 
quality and quantity are most closely linked to lower cognition 
in the executive function and attention domains.38–40 Notably, 
Table 4—Adjusted mean change and 95% confidence intervals of sleep disordered breathing, sleep architecture, sleep fragmentation, and sleep 
duration from linear regression models for change in cognitive score from the sleep examination (visit 4; 1996–1998) to the follow-up neurocognitive 
examination (visit 5; 2011–2013) (z-scores standardized to visit 2; 1990–1992).
  
1 SD
Delayed Word Recall 
Estimate (95% CI)
 
P
Word Fluency
Estimate (95% CI)
 
P
Digit Symbol Substitution
Estimate (95% CI)
 
P
Hypoxemia and disordered breathing
Percentage sleep time SaO2 < 90% 7.9 −0.01 (−0.10, 0.09) 0.92 0.01 (−0.03, 0.05) 0.65 −0.01 (−0.05, 0.03) 0.61
Apnea-hypopnea index 12.5 −0.02 (−0.10, 0.06) 0.61 0.02 (−0.02, 0.07) 0.31 −0.04 (−0.08, 0.00) 0.07
# Apnea/hypopnea events per night 83.4 −0.01 (−0.08, 0.07) 0.85 0.03 (−0.01, 0.07) 0.11 −0.03 (−0.07, 0.01) 0.13
Sleep fragmentation
Arousal index 9.5 −0.03 (−0.10, 0.05) 0.52 −0.03 (−0.07, 0.01) 0.16 0.00 (−0.04, 0.03) 0.86
Average sleep WASO 37.6 −0.05 (−0.13, 0.04) 0.28 0.00 (−0.04, 0.05) 0.83 0.01 (−0.02, 0.04) 0.47
Average sleep duration
< 7 h 0.01 (−0.21, 0.22) −0.06 (−0.17, 0.05) −0.10 (−0.18, −0.02)
7 h Reference Reference Reference
8 h 0.16 (−0.03, 0.35) 0.10 (0.00, 0.20) 0.02 (−0.05, 0.10)
≥ 9 h −0.14 (−0.50, 0.23) 0.02 (−0.15, 0.20) 0.05 (−0.10, 0.21)
P for difference 0.24 0.06 0.02
Adjusted for age, sex, field center, and educational ascertainment. Results reported per change in standard deviation of the exposure. P for trend from 
linear regression model with average sleep duration modeled as a categorical variable. P for difference based on a Wald chi-square 3 degrees of freedom 
test. CI, confidence interval; SaO2, saturation of oxygen; WASO, wake after sleep onset.
Table 5—Estimates and 95% confidence intervals per standard deviation of cognitive test score (2011–2013) by obstructive sleep apnea category 
(1996–1998).
 Normal Mild Moderate Severe P for trend
n 513 273 118 51
Delayed Word Recall Reference −0.07 (−0.21, 0.07) −0.04 (−0.23, 0.16) −0.11 (−0.39, 0.16) 0.36
Word Fluency Reference 0.02 (−0.11, 0.16) −0.02 (−0.20, 0.17) −0.04 (−0.30, 0.22) 0.82
Digit Symbol Substitution Reference −0.07 (−0.18, 0.05) −0.06 (−0.22, 0.11) −0.13 (−0.36, 0.10) 0.18
Trail Making Test, part A Reference −0.10 (−0.20, 0.00) −0.10 (−0.24, 0.04) −0.15 (−0.34, 0.04) 0.03
Trailing Making Test, part B Reference −0.03 (−0.15, 0.09) −0.01 (−0.18, 0.15) 0.03 (−0.21, 0.27) 0.98
Digit Span Backwards Reference −0.03 (−0.17, 0.11) 0.00 (−0.19, 0.19) 0.14 (−0.12, 0.41) 0.55
Logical Memory Test, part A Reference 0.03 (−0.11, 0.18) 0.03 (−0.16, 0.23) 0.05 (−0.22, 0.33) 0.61
Logical Memory Test, part B Reference −0.01 (−0.16, 0.13) −0.03 (−0.23, 0.16) 0.17 (−0.11, 0.45) 0.58
Incidental Learning, digit-symbol pairs Reference 0.07 (−0.07, 0.22) 0.01 (−0.19, 0.21) 0.23 (−0.06, 0.52) 0.21
Clock Time Perception Reference −0.05 (−0.17, 0.07) 0.01 (−0.15, 0.18) −0.29 (−0.52, −0.05) 0.11
Animal Naming Reference −0.03 (−0.17, 0.11) −0.14 (−0.33, 0.06) −0.17 (−0.45, 0.10) 0.10
Boston Naming Test Reference −0.01 (−0.10, 0.09) −0.01 (−0.15, 0.12) −0.05 (−0.24, 0.14) 0.64
Mini-Mental State Examination Reference 0.01 (−0.11, 0.14) 0.13 (−0.05, 0.30) 0.05 (−0.19, 0.29) 0.28
Adjusted for age, sex, field center, and educational ascertainment. P for trend from linear regression model with obstructive sleep apnea modeled as an 
ordinal variable.
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a prior cross-sectional analysis of the ARIC data revealed no 
association between the severity of OSA and cognitive perfor-
mance.41 Yet, ARIC participants were 53–74 y old at the time, 
and the analysis may have taken place too early in the natural 
history of the disease.
Limitations of the current study are the single assessment of 
sleep, incomplete information on continuous positive airway 
pressure intervention during the follow-up period, that the eti-
ologically relevant timeframe for the association between sleep 
and cognitive decline could be outside the examined window, 
that all cognitive tests were not administered at the time of the 
SHHS, and that selection bias may have been present. Ana-
lyzing only those persons who attended a visit, when the likeli-
hood of attending the visit is associated with both abnormal 
sleep characteristics and cognition, may provide biased re-
sults. Of the original SHHS participants, one-third did not at-
tend the follow-up neurocognitive examination due to either 
death or attrition. We attempted to account for selection bias 
by using IPAW models. Results of these analyses were similar 
to those from standard analyses. Our study also has important 
strengths, including objectively measured sleep assessments, 
a relatively large sample size, the availability of information 
on numerous potential confounders, and the assessment of an 
extensive battery of cognitive tests, which were administered 
by centrally trained staff.
To summarize, in this community-based study of nearly 
1,000 men and women the associations of the severity of OSA, 
sleep fragmentation, nocturnal hypoxemia, and habitual sleep 
duration with cognitive decline over 15 y of follow-up were re-
soundingly null. However, although we observed no significant 
associations, it remains possible that in more acute settings 
poor sleep quality may be associated with cognitive decline, 
particularly among the elderly.
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